Morepen Laboratories Q2 Revenue Rises 81% to Rs 755 Crore
Morepen Laboratories reported second-quarter revenue of Rs 755 crore, up 81% year on year, for the quarter ended September 30.
Morepen Laboratories reports strong second-quarter growth in revenue, EBITDA and profit, supported by commercial CDMO supplies, exports and medical devicesMorepen Laboratories Limited reported an 81 per cent year-on-year increase in revenue to Rs 755 crore for the second quarter ended 30 September…